Literature DB >> 36263308

Value Insider Season 1 Episode 2: How to Measure Quality of Life and Utility? (QoL) [Podcast].

Nancy J Devlin1, Elisabeth Sophia Hartgers-Gubbels2, Michael Chambers3.   

Abstract

How do we measure quality of life and utility of interventions? In this episode of the Value Insider podcast, host Mike Chambers speaks with Prof. Nancy Devlin about incorporating quality of life in value assessment. Prof. Devlin is professor of health economics at the University of Melbourne. Her past roles include Director of Research at the Office of Health Economics (OHE) London, Professor of Health Economics at City University of London, and she has been director of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR). She is the Chair of the Board of the EuroQol Research Foundation, the international research organization which has developed and maintains the EQ-5D patient-reported outcome (PRO) instrument. Prof Devlin explains the value of the patient voice and how it can be measured and taken into account when considering the value of healthcare interventions.
© 2022 Boehringer Ingelheim International GmbH.

Entities:  

Keywords:  HTA; health economics and outcomes research; health technology assessment; healthcare reimbursement; market access; payer; value demonstration

Year:  2022        PMID: 36263308      PMCID: PMC9574672          DOI: 10.2147/IJGM.S390090

Source DB:  PubMed          Journal:  Int J Gen Med        ISSN: 1178-7074


  15 in total

Review 1.  Willingness to pay for a quality-adjusted life year: in search of a standard.

Authors:  R A Hirth; M E Chernew; E Miller; A M Fendrick; W G Weissert
Journal:  Med Decis Making       Date:  2000 Jul-Sep       Impact factor: 2.583

2.  Disability-adjusted life years: a critical review.

Authors:  S Anand; K Hanson
Journal:  J Health Econ       Date:  1997-12       Impact factor: 3.883

3.  Incorporating Quantitative Patient Preference Data into Healthcare Decision Making Processes: Is HTA Falling Behind?

Authors:  David John Mott
Journal:  Patient       Date:  2018-06       Impact factor: 3.883

4.  Value to Whom? The Patient Voice in the Value Discussion.

Authors:  Eleanor M Perfetto; Elisabeth M Oehrlein; Marc Boutin; Sarah Reid; Eric Gascho
Journal:  Value Health       Date:  2017-02       Impact factor: 5.725

5.  Clinical Utility and User Perceptions of a Digital System for Electronic Patient-Reported Symptom Monitoring During Routine Cancer Care: Findings From the PRO-TECT Trial.

Authors:  Ethan Basch; Angela M Stover; Deborah Schrag; Arlene Chung; Jennifer Jansen; Sydney Henson; Philip Carr; Brenda Ginos; Allison Deal; Patricia A Spears; Mattias Jonsson; Antonia V Bennett; Gita Mody; Gita Thanarajasingam; Lauren J Rogak; Bryce B Reeve; Claire Snyder; Lisa A Kottschade; Marjory Charlot; Anna Weiss; Deborah Bruner; Amylou C Dueck
Journal:  JCO Clin Cancer Inform       Date:  2020-10

6.  The Oxford hip score: the patient's perspective.

Authors:  Vikki Wylde; Ian D Learmonth; Victoria J Cavendish
Journal:  Health Qual Life Outcomes       Date:  2005-10-31       Impact factor: 3.186

Review 7.  Extending basic principles of measurement models to the design and validation of Patient Reported Outcomes.

Authors:  Mark J Atkinson; Richard D Lennox
Journal:  Health Qual Life Outcomes       Date:  2006-09-22       Impact factor: 3.186

8.  The patient voice in research-evolution of a role.

Authors:  Dianne S Johnson; Mary T Bush; Susan Brandzel; Karen J Wernli
Journal:  Res Involv Engagem       Date:  2016-02-22

Review 9.  EQ-5D and the EuroQol Group: Past, Present and Future.

Authors:  Nancy J Devlin; Richard Brooks
Journal:  Appl Health Econ Health Policy       Date:  2017-04       Impact factor: 2.561

10.  Using Health Utility Index (HUI) for measuring the impact on health-related quality of Life (HRQL) among individuals with chronic diseases.

Authors:  Frank Mo; Bernard C K Choi; Felix C K Li; Joav Merrick
Journal:  ScientificWorldJournal       Date:  2004-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.